Related Experiment Video

Updated: Aug 14, 2026

GABA-activated Single-channel and Tonic Currents in Rat Brain Slices
09:59

GABA-activated Single-channel and Tonic Currents in Rat Brain Slices

Published on: July 17, 2011

Block of T -Type Ca(2+) Channels Is an Important Action of Succinimide Antiabsence Drugs

John R. Huguenard1

  • 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California.

Epilepsy Currents
|August 17, 2004
PubMed

Insights

Ethosuximide’s antiepileptic effect in absence epilepsy is linked to T-type calcium channels. New evidence from transgenic models supports their major role in seizure generation and drug action.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • The precise antiepileptic mechanism of ethosuximide, particularly its interaction with calcium channels, remains debated.
  • Absence seizures are a type of epilepsy characterized by brief lapses in awareness.

Purpose of the Study:

  • To investigate the role of calcium channel blockade in ethosuximide's antiepileptic effects.
  • To clarify the involvement of T-type calcium channels in absence epilepsy and ethosuximide's therapeutic action.

Main Methods:

  • Utilized transgenic animal models to study epilepsy mechanisms.
  • Employed heterologous expression systems to analyze ion channel function.
  • Examined the effects of ethosuximide on T-type calcium channels.

Main Results:

  • Recent evidence strongly supports a significant role for T-type calcium channels.
  • These channels are implicated in the generation of absence seizures.
  • Ethosuximide's action in human absence epilepsy is associated with these channels.

Conclusions:

  • T-type calcium channels play a crucial role in the pathophysiology of absence epilepsy.
  • Ethosuximide exerts its antiepileptic effects, at least in part, through modulation of T-type calcium channels.
  • This finding provides a clearer understanding of ethosuximide's mechanism of action in absence epilepsy.

More Related Videos

Generation of Local CA1 γ Oscillations by Tetanic Stimulation08:02

Generation of Local CA1 γ Oscillations by Tetanic Stimulation

Published on: August 14, 2015

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation09:39

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation

Published on: June 7, 2016

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...